As has been previously suggested, the European Federation ofPharmaceutical Industries and Associations, announced an enhanced new membership structure at its annual general meeting last month. As well as 16 European pharmaceutical industry trade associations, which until now have comprised the membership of the EFPIA, 40 pharmaceutical companies operating in Europe have been accepted as members.
The companies which have been accepted into the EFPIA as individual members have had to comply with the following criteria:
- do significant original research;
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze